Binding Site Competitors and Similar CompaniesClear all
EKF Diagnostics's competitors and similar companies include SpeeDx and QIAGEN.
 EKF Diagnostics EKF Diagnostics Holdings is a company that manufactures point-of-care (POCT) devices and tests for hemoglobin, glycated hemoglobin (HbA1c), glucose, and lactate. |  SpeeDx SpeeDx is a provider of multiplex quantitative polymerase chain reaction (qPCR) and isothermal amplification solutions for clinical diagnostics. | ||
Founding Date | Founding Date 1990 | Founding Date 2009 | Founding Date 1984 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations Penarth, GB HQ Shanghai, CN Barleben, DE Leipzig, DE Boerne, US Elkhart, US | Locations Eveleigh, AU HQ London, GB Austin, US | Locations Venlo, NL HQ Clayton, AU São Paulo, BR Toronto, CA Beijing, CN Guangzhou, CN Shanghai, CN see more |
Employees | Employees 303 | Employees 842% decrease | Employees 5,6541% decrease |
Valuation ($) | Valuation ($) 157.5 m | Valuation ($) N/A | Valuation ($) 9.3 b |
Financial | |||
Revenue (est.) | Revenue (est.) £51.6m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $2.1b (FY, 2025) |
Cost of goods | Cost of goods £19.7m (FY, 2025) | Cost of goods N/A | Cost of goods $577.3m (FY, 2025) |
Gross profit | Gross profit £32.1m (FY, 2025) | Gross profit N/A | Gross profit $1.5b (FY, 2025) |
Net income | Net income £2.5m (FY, 2025) | Net income N/A | Net income $437m (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 30m | Total funding raised $ 4m |
For sources of this data, please see the company profile
View Company Profiles
SpeeDx
HQ
Eveleigh, AU
Employees
84↓ 2% decrease
SpeeDx is a provider of multiplex quantitative polymerase chain reaction (qPCR) and isothermal amplification solutions for clinical diagnostics.
View company
QIAGEN
HQ
Venlo, NL
Employees
5,654↓ 1% decrease
QIAGEN is a company that provides sample technology solutions.
View company